Figueira J, Fletcher E, Massin P, Silva R, Bandello F, Midena E, Varano M, Sivaprasad S, Eleftheriadis H, Menon G, et al. Ranibizumab plus panretinal photocoagulation versus panretinal photocoagulation alone for high-risk proliferative diabetic retinopathy (PROTEUS study). Ophthalmology. 2018;125:691–700.

Chatziralli I, Kabanarou S, Parikakis E, CHATZIRALLIS A, Xirou T, Mitropoulos P. Risk factors for central serous chorioretinopathy: multivariate approach in a case-control study. In: ACTA OPHTHALMOLOGICA. Vol. 96. WILEY 111 RIVER ST, HOBOKEN 07030-5774, NJ USA; 2018. pp. 21–21.

Moschos MM, Gouliopoulos NS, Kalogeropoulos C, Androudi S, Kitsos G, Ladas D, Tsatsos M, Chatziralli I. Psychological aspects and depression in patients with symptomatic keratoconus. Journal of ophthalmology. 2018;2018.

Chatziralli I, Regan SO, Mohamed R, Talks J, Sivaprasad S. Intravitreal aflibercept for neovascular age-related macular degeneration in patients aged 90 years or older: 2-year visual acuity outcomes. Eye. 2018;32:1523–1529.

Chatziralli I. Editorial-suboptimal response to intravitreal anti-VEGF treatment for patients with diabetic macular edema: is there any point in switching treatment. Eur Rev Med Pharmacol Sci. 2018;22:5047–50.

Chatziralli I, Theodossiadis P, Theodossiadis GP. Optic disk pit maculopathy: current management strategies. Clinical Ophthalmology (Auckland, NZ). 2018;12:1417.

Theodorou-Kanakari A, Karampitianis S, Karageorgou V, Kampourelli E, Kapasakis E, Theodossiadis P, Chatziralli I. Current and emerging treatment modalities for Leber’s hereditary optic neuropathy: a review of the literature. Advances in therapy. 2018;35:1510–1518.

Chatziralli I, Vlachodimitropoulou A, Daoula C, Vrettou C, Galani E, Theodossiadis G, Theodossiadis P. Eplerenone in the treatment of central serous chorioretinopathy: a review of the literature. International journal of retina and vitreous. 2018;4:1–5.

Chatziralli I, Dimitriou E, Kabanarou S, CHATZIRALLIS A, Xirou T, Theodossiadis G, Theodossiadis P. Fundus autofluorescence changes in diabetic retinopathy. In: ACTA OPHTHALMOLOGICA. Vol. 96. WILEY 111 RIVER ST, HOBOKEN 07030-5774, NJ USA; 2018. pp. 21–21.

Xirou T, Garnavou-Xirou C, Kabanarou S, Gkizis I, Bitza P, Koutropoulou N, Kontou E, Chatziralli I. The role of disorganization of inner retinal layers as predictive factor in patients with epiretinal membrane. In: ACTA OPHTHALMOLOGICA. Vol. 96. WILEY 111 RIVER ST, HOBOKEN 07030-5774, NJ USA; 2018. pp. 139–139.

Chatziralli I, Dimitriou E, Saitakis G, CHATZIRALLIS A, Theodossiadis G, Theodossiadis P. Coexistence of diabetic retinopathy and age-related macular degeneration: epidemiology and management. In: ACTA OPHTHALMOLOGICA. Vol. 96. WILEY 111 RIVER ST, HOBOKEN 07030-5774, NJ USA; 2018. pp. 21–21.

Chatziralli IP, Theodossiadis PG, Steel DHW. Internal limiting membrane peeling in macular hole surgery; why, when, and how?. Retina. 2018;38:870–882.

Chatziralli I, Theodossiadis G, Panagiotidis D, Pousoulidi P, Theodossiadis P. Choriocapillaris vascular density changes in patients with drusen: cross-sectional study based on optical coherence tomography angiography findings. Ophthalmology and therapy. 2018;7:101–107.

Chatziralli I, Theodossiadis P, Theodossiadis G, Asproudis I. Perspectives on diagnosis and management of adult idiopathic intracranial hypertension. Graefe's Archive for Clinical and Experimental Ophthalmology. 2018;256:1217–1224.

Zola M, Chatziralli I, Menon D, Schwartz R, Hykin P, Sivaprasad S. Evolution of fundus autofluorescence patterns over time in patients with chronic central serous chorioretinopathy. Acta ophthalmologica. 2018;96:e835–e839.

Chatziralli I, Chatzipantelis A, Dimitriou E, Mpourouki E, Theodossiadis G, Theodossiadis P. Refractive changes after intravitreal ranibizumab injections for diabetic macular oedema. Clinical and Experimental Optometry. 2018;101:397–399.

Moschos MM, Laios K, Androudi S, Ladas DS, Chatziralli IP. Anti-platelet effects of vitamin supplements in age-related macular degeneration: an in vitro study. Cutaneous and ocular toxicology. 2018;37:207–209.

Chatziralli IP. The role of glycemic control and variability in diabetic retinopathy. Diabetes Therapy. 2018;9:431–434.

Chatziralli I, Stavrakas P, Theodossiadis G, Ananikas K, Dimitriou E, Theodossiadis P. The impact of epiretinal membrane in neovascular age-related macular degeneration treatment: a spectral-domain optical coherence tomography study. In: Seminars in ophthalmology. Vol. 33. Taylor & Francis; 2018. pp. 651–656.

Chatziralli I, Theodossiadis G, Panagiotidis D, Pousoulidi P, Theodossiadis P. Choriocapillaris’ alterations in the presence of reticular pseudodrusen compared to drusen: study based on OCTA findings. International ophthalmology. 2018;38:1887–1893.

Chatziralli I, Theodossiadis G, Chatzirallis A, Parikakis E, Mitropoulos P, Theodossiadis P. Ranibizumab for retinal vein occlusion: predictive factors and long-term outcomes in real-life data. Retina. 2018;38:559–568.

Moschos MM, Chatziralli IP. Evaluation of choroidal and retinal thickness changes in Parkinson’s disease using spectral domain optical coherence tomography. In: Seminars in ophthalmology. Vol. 33. Taylor & Francis; 2018. pp. 494–497.